Hydro_Logo_Vertical_Blue_CMYK.png
Hydro's Board seeks authority for share buyback
March 03, 2004 02:57 ET | Norsk Hydro
The Board of Norsk Hydro ASA will at the company's Annual General Meeting 11 May 2004 ask for authorisation to buy back shares.   Under this authorisation, the Board may buy up to 2 808 810 of...
TeliaSonera
NetCom Lowers Prices for Pre-Paid SMS
March 03, 2004 02:34 ET | TeliaSonera
STOCKHOLM, Sweden, March 3, 2004 (PRIMEZONE) -- TeliaSonera's subsidiary NetCom is reducing the price on pre-paid SMS an additional 0.10 NOK to 0.69 NOK per SMS. This means that all NetCom SMS users...
ScottishPower's Pacificorp Granted $23 Million in Wyoming General Rate Case
March 03, 2004 02:16 ET | Scottish Power PLC
GLASGOW, U.K., March 3, 2004 (PRIMEZONE) -- ScottishPower today announces that on 2 March the Wyoming Public Service Commission (WPSC) granted approximately $23 million of additional annual revenues...
Cantos
InterbrewAmBev - video interview with Interbrew CEO
March 03, 2004 01:47 ET | Cantos
BRUSSELS, Belgium, March 3, 2004 (PRIMEZONE) -- Interbrew and AmBev establish InterbrewAmBev Indepth interview available now on www.cantos.com with John Brock, Chief Executive Officer,...
Positive Phase II Results for Basilea's Novel First-In-Class Antibiotic
March 03, 2004 01:39 ET | Basilea Pharmaceutica Ltd
BASEL, Switzerland, March 3, 2004 (PRIMEZONE) -- Basilea Pharmaceutica AG today announced positive phase II results for BAL5788 in the indication of complicated skin and skin structure infections...
Basilea-Logo.jpg
Positive Phase II Ergebnisse für Basileas erstes Antibiotikum einer neuen Generation
March 03, 2004 01:30 ET | Basilea Pharmaceutica AG
Basel, Schweiz, 3 März 2004   Basilea Pharmaceutica AG gab heute positive Phase II Ergebnisse für BAL5788 in der Indikation der komplizierten Haut- und Weichteilinfektionen bekannt. ...
Basilea-Logo.jpg
Positive Phase II Results for Basilea's Novel First-In-Class Antibiotic
March 03, 2004 01:30 ET | Basilea Pharmaceutica AG
Basel, Switzerland, 3 March 2004   Basilea Pharmaceutica AG today announced positive phase II results for BAL5788 in the indication of complicated skin and skin structure infections...
Ahold Divests Thai Operation, Withdrawal from Asia Completed
March 03, 2004 01:10 ET | Ahold NV
ZAANDAM, The Netherlands, March 03, 2004 (PRIMEZONE) -- Ahold today announced it has reached agreement on the sale of its stake in CRC.Ahold, operating in Thailand, to its partner, the Central Group....
logo.jpg
Ahold divests Thai operation, withdrawal from Asia completed
March 03, 2004 01:03 ET | Ahold Delhaize
Zaandam, The Netherlands, March 3, 2004 - Ahold today announced it has reached agreement on the sale of its stake in CRC.Ahold, operating in Thailand, to its partner, the Central Group. The...
logo.jpg
Ahold verkoopt Thaise activiteiten en trekt zich terug uit Azië
March 03, 2004 01:00 ET | Ahold Delhaize
Zaandam, 3 maart 2004 - Ahold heeft vandaag bekendgemaakt dat er overeenstemming is bereikt over de verkoop van haar aandeel in CRC.Ahold in Thailand aan haar partner, de Central Group. De verkoop,...